Clinical Features and Treatment Outcomes of Fournier's Gangrene in a Single Tertiary Emergency Hospital: Simplified Fournier's Gangrene Severity Index Score is a Predictor for Death

Overview

Journal Glob Health Med

Specialty Public Health

Date 2024 Jan 1

PMID 38162432

Authors

Taichi Shiratori

Masaki Nakamura

Akihiro Naito

Masahiro Yamamoto

Yoshihiro Okura

Jun Yamakawa

Haruki Kume

Motofumi Suzuki

Affiliations

Soon will be listed here.

Abstract

To assess the predictive reliability of the Simplified Fournier's Gangrene Severity Index Score (SFGSI) for mortality in Japanese patients with Fournier's gangrene (FG), we compared the clinical features and outcomes of a patient sample with the SFGSI. The medical records of 36 patients diagnosed with FG at our hospital between October 2007 and September 2022 were reviewed retrospectively. Clinical and laboratory variables, including SFGSI, were evaluated and predictive factors for fatality were investigated using multivariate logistic regression analysis. The median age and body mass index were 65 and 24.2, respectively. Eight patients had cooccurring chronic kidney disease and 23 had diabetes. None were taking sodium-glucose co-transporter-2 (SGLT-2) inhibitors. The causative organisms were diverse, and no specific trends in causative organisms were observed. 26 patients underwent debridement of necrotic tissue including eight colostomies, two orchiectomies, and one cystectomy. Multivariate logistic regression analysis revealed that SFGSI alone was an independent predictor of case fatality, with an odds ratio of 20.167 (95% CI: 1.66-245.53). In conclusion, the fatality rate was 19.4%, which was comparable to that reported in other studies. The SFGSI was an independent predictor of mortality in this study.

References

Selvi I, Aykac A, Baran O, Burlukkara S, Ozok U, Sunay M . A different perspective for morbidity related to Fournier's gangrene: which scoring system is more reliable to predict requirement of skin graft and flaps in survivors of Fournier's gangrene?. Int Urol Nephrol. 2019; 51(8):1303-1311. DOI: 10.1007/s11255-019-02188-0. View

Hagedorn J, Wessells H . A contemporary update on Fournier's gangrene. Nat Rev Urol. 2016; 14(4):205-214. DOI: 10.1038/nrurol.2016.243. View

Charlson M, Pompei P, Ales K, MacKenzie C . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-83. DOI: 10.1016/0021-9681(87)90171-8. View

Gawande A, Kwaan M, Regenbogen S, Lipsitz S, Zinner M . An Apgar score for surgery. J Am Coll Surg. 2007; 204(2):201-8. DOI: 10.1016/j.jamcollsurg.2006.11.011. View

Bowen D, Juliebo-Jones P, Somani B . Global outcomes and lessons learned in the management of Fournier's gangrene from high-volume centres: findings from a literature review over the last two decades. World J Urol. 2022; 40(10):2399-2410. DOI: 10.1007/s00345-022-04139-4. View

Jahir T, Hossain S, Bagum M, Saidi A, Risal R, Schmidt M . A Rare but Life-Threatening Case of Fournier's Gangrene Caused by Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor, Empagliflozin. Cureus. 2022; 14(9):e29264. PMC: 9576122. DOI: 10.7759/cureus.29264. View

Sorensen M, Krieger J . Fournier's Gangrene: Epidemiology and Outcomes in the General US Population. Urol Int. 2016; 97(3):249-259. DOI: 10.1159/000445695. View

Lin T, Ou C, Tzai T, Tong Y, Chang C, Cheng H . Validation and simplification of Fournier's gangrene severity index. Int J Urol. 2014; 21(7):696-701. DOI: 10.1111/iju.12426. View

Serrano Olave A, Moral A, Banon C, Gonzalez Mesa E, Jimenez Lopez J . Fournier's Gangrene under Sodium-Glucose Cotransporter-2 Inhibitors Therapy in Gynecological Patients. Int J Environ Res Public Health. 2022; 19(10). PMC: 9141785. DOI: 10.3390/ijerph19106261. View

10.

Sparenborg J, Brems J, Wood A, Hwang J, Venkatesan K . Fournier's gangrene: a modern analysis of predictors of outcomes. Transl Androl Urol. 2019; 8(4):374-378. PMC: 6732100. DOI: 10.21037/tau.2019.03.09. View

11.

Sakamoto A, Kaneko T, Kanatani A, Kimura M, Takahashi S, Yamada Y . [FOURNIER GANGRENE: AN ANALYSIS OF 15 CASES]. Nihon Hinyokika Gakkai Zasshi. 2022; 112(2):65-69. DOI: 10.5980/jpnjurol.112.65. View

12.

Arora A, Rege S, Surpam S, Gothwal K, Narwade A . Predicting Mortality in Fournier Gangrene and Validating the Fournier Gangrene Severity Index: Our Experience with 50 Patients in a Tertiary Care Center in India. Urol Int. 2019; 102(3):311-318. DOI: 10.1159/000495144. View

13.

Sugihara T, Yasunaga H, Horiguchi H, Fujimura T, Ohe K, Matsuda S . Impact of surgical intervention timing on the case fatality rate for Fournier's gangrene: an analysis of 379 cases. BJU Int. 2012; 110(11 Pt C):E1096-100. DOI: 10.1111/j.1464-410X.2012.11291.x. View

14.

Laor E, Palmer L, Tolia B, Reid R, Winter H . Outcome prediction in patients with Fournier's gangrene. J Urol. 1995; 154(1):89-92. View

15.

Tenorio C, Lima S, Albuquerque A, Cavalcanti M, Teles F . Risk factors for mortality in fournier's gangrene in a general hospital: use of simplified founier gangrene severe index score (SFGSI). Int Braz J Urol. 2017; 44(1):95-101. PMC: 5815538. DOI: 10.1590/S1677-5538.IBJU.2017.0193. View

16.

Erol B, Tuncel A, Tok A, Hanci V, Sari U, Sendogan F . Low magnesium levels an important new prognostic parameter can be overlooked in patients with Fournier's gangrene: a multicentric study. Int Urol Nephrol. 2015; 47(12):1939-45. DOI: 10.1007/s11255-015-1131-9. View

17.

Lin T, Su C, Chang Y, Chen I, Ou C, Cheng Y . The sufficient multidisciplinary specialists under a government-led health care system associated with the downward mortality trend of Fournier's gangrene in Taiwan. Int J Urol. 2022; 30(2):182-189. DOI: 10.1111/iju.15081. View

18.

Yilmazlar T, Ozturk E, Ozguc H, Ercan I, Vuruskan H, Oktay B . Fournier's gangrene: an analysis of 80 patients and a novel scoring system. Tech Coloproctol. 2010; 14(3):217-23. DOI: 10.1007/s10151-010-0592-1. View

19.

Tuncel A, Keten T, Aslan Y, Kayali M, Erkan A, Koseoglu E . Comparison of different scoring systems for outcome prediction in patients with Fournier's gangrene: experience with 50 patients. Scand J Urol. 2014; 48(4):393-9. DOI: 10.3109/21681805.2014.886289. View

20.

Roghmann F, von Bodman C, Loppenberg B, Hinkel A, Palisaar J, Noldus J . Is there a need for the Fournier's gangrene severity index? Comparison of scoring systems for outcome prediction in patients with Fournier's gangrene. BJU Int. 2012; 110(9):1359-65. DOI: 10.1111/j.1464-410X.2012.11082.x. View